Skip to content

Clinical trials

Phase 2 Prostatic Neoplasms trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 2 Country / region: Russia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20042
20051
20073
20091
20121
20142
20162

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ferring Pharmaceuticals3
Ascenta Therapeutics1
Astellas Pharma Europe B.V.1
Astellas Pharma Global Development, Inc.1
AstraZeneca1
Centocor Research & Development, Inc.1
Centocor, Inc.1
Eisai Inc.1
GlaxoSmithKline1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms14
Disease1
Neoplasm Metastasis1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.